Angiotensin receptor blockers reduce erythrocyte sedimentation rate levels in patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 67, Issue 11, 2008, Pages 1646-1647

  Perry, Martin Edward ^a   Chee, M M ^a   Ferrell, W R ^a   Lockhart, J C ^b   Sturrock, R D ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; RAMIPRIL;

ANTIINFLAMMATORY ACTIVITY; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; HUMANS; RETROSPECTIVE STUDIES;

EID: 54349110168     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.082917     Document Type: Letter

References (7)

1. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J. Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 2001;10:321-9.
2. 1 receptor characteristics of angiotensin analogue binding in human synovium. Br J Pharmacol 1994;112:435-42.
3. Dalbeth N, Edwards J, Fairchild S, Callan M, Hall FC. The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis. Rheumatology 2005;44:24-31.
4. 1 receptor as a novel therapeutic target in rheumatoid arthritis. Arthritis Rheum 2007;56:441-7.
5. Takeda T, Hoshida S, Nishino M, Tanouchi J, Otsu K, Hori M. Relationship between effects of statins, aspirin, and angiotensin II modulators on high sensitive C-reactive protein levels. Atherosclerosis 2003;169:155-8.
6. Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how "high grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108:2957-63.
7. McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakova O, Ford I, et al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): a double-blind randomised placebo-controlled trial. Lancet 2004;108:2957-63.